#USA #AI Innovation #Washington, DC #Sorcero #Dipanwita Das

Sorcero's Remarkable Recognition in AI

In a groundbreaking acknowledgment within the realm of artificial intelligence, Dipanwita Das, the CEO and co-founder of Sorcero, has been named one of the only three female founders in the life sciences sector to be included in the prestigious 2026 '100 Women in AI' list. This honor underscores her significant contributions to the field and the innovative strides made by her company, Sorcero, which operates as an AI-driven intelligence platform specifically designed for life sciences.

Das joins an exclusive group of innovators, including leaders from some of the world's most formidable AI companies, such as Anthropic, OpenAI, NVIDIA, AMD, Microsoft, and Google. The selection process for the 100 Women in AI list evaluated nominees based on various criteria, including their seniority, substantial achievements, influence, and real-world impact, drawing from over 1,000 nominations globally.

The Role of AI in Life Sciences

The critical applications of AI in healthcare cannot be overstated. As the industry grapples with the challenge of delivering precise therapies to patients promptly, AI solutions like those developed by Sorcero play a vital role. Sorcero’s platform stands out for its ability to effectively turn fragmented scientific data into actionable insights with unprecedented accuracy. Impressively, the platform achieves a clinical accuracy of 96.1%, which surpasses FDA regulatory requirements while significantly reducing the time required for scientific data analysis by over 72%.

The implications of this innovative platform are profound, as it enables medical professionals to bring evidenced-based therapies to patients more efficiently. “I’m incredibly honored to be named alongside such an impressive group of women who are pioneering in the world of AI,” Das expressed, emphasizing the role of timely scientific evidence in ensuring patient safety and improving health outcomes.

Recent Successes and Innovations

Sorcero's acknowledgment as a key player in the AI space coincided with a fruitful year for the company. In 2025, Sorcero secured a substantial $42.5 million in Series B funding led by NewSpring Capital and was recognized as Google Cloud's Partner of the Year for Healthcare and Life Sciences. Additionally, Sorcero made its debut on the Inc. 5000 list ranking 684 among America’s fastest-growing private companies and was celebrated by Fortune and Fast Company as one of the most innovative companies in its sector.

The innovative endeavors of Sorcero, as articulated by Das, focus on expediting the reach of therapies, particularly in light of the complexities surrounding precision medicines and specialty drugs expected to dominate the healthcare landscape in the coming decade. By enhancing systems that monitor therapies post-market, Sorcero aims to provide reliable safety measures for patients.

Conclusion

As part of the ongoing recognition of outstanding women in AI, Das and Sorcero continue to influence the way AI is built and adopted in critical sectors such as life sciences. The insights from Sorcero are invaluable to pharmaceutical companies, allowing them to overcome market challenges and fast-track life-altering treatments to those in need, thereby demonstrating the significant potential of AI in transforming healthcare.

For those interested in learning more about the honorees, Das’ full profile can be accessed at 100 Women in AI, and the complete list of 2026 honorees is available at Full List 2026.